跳至主要内容
临床试验/NCT02891655
NCT02891655已完成不适用

KERatoconus and Metalloproteinases InvesTigation

Fondation Ophtalmologique Adolphe de Rothschild1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2016年12月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
23
试验地点
1
主要终点
expression of the Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) in epithelial cells

研究概览

简要总结

Corneal stromal thinning observed in keratoconic eyes could result from an increased synthesis of MMP at the level of the anterior stroma and the corneal epithelium induced by an overexpression of the Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) and Galectin-3 by epithelial cells. A differential expression of EMMPRIN, Galectin-3 and metalloproteinases (MMP) may be observed between the apex of the keratoconus and the peripheral cornea. Highlighting the implication of EMMPRIN and Galectin-3 could lead to the development of specific inhibitors to slow or to stop keratoconus evolution.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age > 18 years old
  • Patient with keratoconus undergoing corneal collagen cross-linking (epithelium-off methods)
  • Patient with keratoconus undergoing his first corneal graft for optical indication (control)

排除标准

  • Patient with keratoconus undergoing corneal graft for tectonic indication
  • Patient undergoing corneal refractive surgery (refractive photokeratectomy) with a normal topography, a normal slit lamp examination and no previous ophthalmic condition (control)
  • pregnant or breast feeding patient
  • patient under judiciary protection
  • patient opposition to participate in the study

结局指标

主要结局

expression of the Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) in epithelial cells

时间窗: baseline

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验